Hepatitis: Risks for the surgeon

American Surgeon

Volumn 66, Issue 2, 2000, Pages 178-183

  Fry, Donald E ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS ANTIBODY; HEPATITIS B VACCINE;

ACUTE DISEASE; CHRONIC DISEASE; CONFERENCE PAPER; DELTA AGENT HEPATITIS; HEPATITIS; HEPATITIS B; HEPATITIS C; HEPATITIS G VIRUS; HUMAN; INFECTION RISK; NEEDLESTICK INJURY; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; OCCUPATIONAL SAFETY; OPERATING ROOM; TORQUE TENO VIRUS; VACCINATION; VIRUS TRANSMISSION;

BLOOD-BORNE PATHOGENS; DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL; HEPATITIS, VIRAL, HUMAN; HUMANS; SURGERY;

EID: 0033976731     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (31)

1. Lemon SM. Type A viral hepatitis: New developments in an old disease. N Engl J Med 1985;313:1059-67.
2. Sureau C, Romet-Lemonne JL, Mullins JI, et al. Production of hepatitis B virus by a differentiated human hepatoma cell line after transfections with cloned circular HBV DNA. Cell 1986;47: 37-47.
3. Choo Q-L, Kuo G, Weiner AJ, et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;244:359-62.
4. Wang K-S, Choo Q-L, Weiner AJ, et al. Structure, sequence and expression of the hepatitis delta viral genome. Nature 1986; 323:508-14.
5. Reyes GR, Purdy MA, Kim JP, et al. Isolation of a cDNA from the virus responsible for enteric transmitted non-A, non-B hepatitis. Science 1990;247:1335-9.
6. Linnen J, Wages J Jr, Zhang-Keck Z-Y, et al. Molecular cloning and disease association of hepatitis G virus: A transfusion-transmissible agent. Science 1996;271:505-8.
7. Kuh C, Ward WE. Occupational virus hepatitis: An apparent hazard for medical personnel. JAMA 1950;143:631.
8. Trumbell ML, Greiner DJ. Homologous serum jaundice: An occupational hazard to medical personnel. JAMA 1951;145:965.
9. Shapiro CN. Occupational risk of infection with hepatitis B and hepatitis C virus. Surg Clin North Am 1995;75:1047-56.
10. Seeff LB, Koff RS: Evolving concepts of the clinical and serologic consequences of hepatitis B virus infection. Semin Liver Dis 1986;6:11-22.
11. Ikeda K, Saitoh S, Koida I, et al. A multivariate analysis of risk factors for hepatocellular carcinogenesis: A prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 1993;18:47-53.
12. Lee WM: Hepatitis B virus infection. N Engl J Med 1997; 337:1733-45.
13. Slusarczyk J, Hess G, Meyer zum Buschenfelde K-H. Association of hepatitis B e antigen(HBeAg) with the core of the hepatitis B virus. Liver 1985;5:48-53.
14. Williams WW, Hickson MA, Kane MA, et al. Immunization policies and vaccine coverage among adults: The risk for missed opportunities. Ann Intern Med 1988;108:616-8.
15. Zajac BA, West DJ, McAleer WJ, Scolnick EM: Overview of clinical studies with hepatitis B vaccine made by recombinant DNA. J Infect Dis 1986;13(Suppl A):39-45.
16. AIDS/TB Committee of the Society for Healthcare Epidemiology of America. Management of Healthcare workers infected with hepatitis B virus, hepatitis C virus, human immunodeficiency virus, or other bloodborne pathogens. Infect Control Hosp Epidemiol 1997;18:349-63.
17. Heptonstall J, Collins M, Smith I, et al. Restricting practice of HbeAg positive surgeons: Lessons from hepatitis B outbreaks in England, Wales, and Northern Ireland 1984-93 (Abstr.). Infect Control Hosp Epidemiol 1994;15:344.
18. Harpaz R, von Seidlein L, Averhoff FM, et al. Transmission of hepatitis B virus to multiple patients from a surgeon without evidence of inadequate infection control. N Engl J Med 1996;334: 549-54.
19. Heptonstall J and the Incident Investigation Team. Transmission of hepatitis B to patients from four infected surgeons without hepatitis B e antigen. N Engl J Med 1997;336:178-84.
20. Alter MJ. Community-acquired viral hepatitis B and C in the United States. Gut 1993;34(suppl 2):517-9.
21. Alter MJ. Epidemiology of hepatitis C. Hepatology 1997;26(Suppl 1):62S-65S.
22. Takahashi M, Yamada G, Miyamoto R, et al. Natural course of chronic hepatitis C. Am J Gastroenterol 1993;88:240-3.
23. Resnick RH, Koff R. Hepatitis C related hepatocellular carcinoma: Prevalence and significance. Arch Intern Med 1993;153: 1672-7.
24. Centers for Disease Control. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR 1998;47:1-39.
25. Sodeyama T, Kiyosawa K, Urushikara A, et al. Detection of hepatitis C virus markers and hepatitis C virus genomic-RNA after needlestick accidents. Arch Intern Med 1993;153:1565-72.
26. McHutchison JG, Gordon SC, Schiff ER, et al. Interferon α-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 1998;339:1485-92.
27. Esteban JI, Gomez J, Martell M, et al. Transmission of hepatitis C virus by a cardiac surgeon. N Engl J Med 1996;334: 555-60.
28. Anonymous. Hepatitis C virus transmission from health-care worker to patient. CDR Weekly 1995;5:121.
29. Nishizawa T, Okamoto H, Konishi K, et al. A novel DNA virus (TTV) associated with elevated transaminase levels in post-transfusion hepatitis of unknown etiology. Biochem Biophys Res Commun 1997;241:92-7.
30. Quebbeman EJ, Telford GL, Wadsworth K, et al. Double gloving: Protecting surgeons from blood contamination in the operating room. Arch Surg 1991;127:213.
31. Centers for Disease Control. Protection against viral hepatitis: Recommendations of the immunization practices advisory committee (ACIP). MMWR 1990;39:1-26.